Sign in
4

Changes in Ownership

Eton Pharmaceuticals, Inc. Filed Acc 0001437749-26-032240

Chief Business Officer sold 4,166 shares at $55.07 ($229,406)

  • Chief Business Officer acquired 10,522 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Krempa David · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-02 Exercise or conversion : show line 1 in the form +10,522 47,547 D
2026-10-06 Sale : show line 2 in the form −4,166 $55.07 $229,406 43,381 D
Open-market sales · 4,166 sh · avg $55.07 · $229,406

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-02 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,522 21,044 D
Loading xslF345X06/rdgdoc.xml…